Amyris, Inc. (NASDAQ:AMRS) Belonging to the Oils-Energy sector which surged 16% and closed its last trading session at $0.58.
The company reported its last EPS on 6/30/2016 and is expected to report its next EPS on 11/3/2016. Currently, the stock has a 1 Year Price Target of $2.68.
The consensus recommendation, according to Zacks Investment research, is 2. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 2.33 respectively.
Amyris, Inc. on 6/30/2016 reported its EPS as $-0.06 with the analysts projecting the EPS of the stock as $-0.12. The company beat the analyst EPS Estimate with the difference of $0.06. This shows a surprise factor of 50%.
Many analysts have provided their estimated foresights on Amyris, Inc. Earnings, with 3 analysts believing the company would generate an Average Estimate of $-0.06. Whereas they predicted High and Low Earnings Estimate as $-0.03 and $-0.07 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.55.
Analysts are also projecting an Average Revenue Estimate for Amyris, Inc. as $33.61 Million in the Current Quarter. This estimate is provided by 3 analysts. The High Revenue estimate is predicted as 40.04 Million, while the Low Revenue Estimate prediction stands at 27.8 Million. The company’s last year sales total was 8.59 Million.
For the Current Quarter, the growth estimate for Amyris, Inc. is 89.1%, while for the Next Quarter the stock growth estimate is 88.9%. In the past 5 years, the stock showed growth of 0% per annum. While for the next 5 years, the growth estimate is 30%.
The Company got Downgrade by Deutsche Bank on 10-Feb-12 from Buy to Hold.
Insider Trades for Amyris, Inc. show that the latest trade was made on 31 Aug 2016 where Weaver Karen, the Officer completed a transaction type “Sell” in which 171 shares were traded at a price of $0.41.
Over the period of 6 months, Insider Purchases show a total of 2 transaction in which 10897400 shares were traded. 3 Insider Sales transactions were made totaling 206903 shares traded.
3 analysts projected Price Targets for Amyris, Inc. The analysts believe that the company stock price could grow as high as $4. The Low Price target projection by analysts is $1.25 and the Mean Price Target is $2.68.
Amyris, Inc. (NASDAQ:AMRS) has the market capitalization of $118.5 Million. The company rocked its 52-Week High of $2.57 on Oct 13, 2015 and touched its 52-Week Low of $0.31 on Jun 28, 2016. The stock has Return on Assets (ROA) of -131.3 percent. Return on Equity (ROE) stands at 96.7% and Return on Investment (ROI) of 2780.4 percent.
The stock is currently showing YTD performance of -64.2 Percent. The company has Beta Value of 0.94 and ATR value of 0.04. The Weekly and Monthly Volatility stands at 9.18% and 6.92%.
Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged in the development of farmesene- a molecule, which serves as the base chemical building block for a wide range of renewable products to replace existing products that are derived from petroleum, plant or animal sources and that may be of lower quality or higher price. Amyris INC is headquartered in Emeryville, CA.